» Articles » PMID: 36860246

Pushing the Limits for the Surgical Treatment of Intrahepatic Cholangiocarcinoma

Overview
Date 2023 Mar 2
PMID 36860246
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficacy analysis of drug-eluting beads transcatheter arterial chemoembolization combining systemic chemotherapy and immune checkpoint inhibitors in unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study based on....

Song L, Qingdong W, Shunhang Y, Long L, Guangsheng Z, Guangji Y World J Surg Oncol. 2025; 23(1):21.

PMID: 39856751 PMC: 11761194. DOI: 10.1186/s12957-025-03679-4.

References
1.
Sapisochin G, Ivanics T, Heimbach J . Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?. Hepatology. 2021; 75(2):455-472. DOI: 10.1002/hep.32258. View

2.
Buettner S, Cate D, Bagante F, Alexandrescu S, Marques H, Lamelas J . Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2019; 23(11):2239-2246. PMC: 6831534. DOI: 10.1007/s11605-019-04184-2. View

3.
Wintachai P, Lim J, Techasen A, Lert-Itthiporn W, Kongpetch S, Loilome W . Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. Diagnostics (Basel). 2021; 11(6). PMC: 8228499. DOI: 10.3390/diagnostics11060999. View

4.
Rizzo A, Brandi G . Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat Res Commun. 2021; 27:100354. DOI: 10.1016/j.ctarc.2021.100354. View

5.
Sposito C, Ratti F, Cucchetti A, Ardito F, Ruzzenente A, Di Sandro S . Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol. 2022; 78(2):356-363. DOI: 10.1016/j.jhep.2022.10.021. View